The iLIVE project involves a cohort study in which patients with an estimated life expectancy of six months or less are followed until they die. In total, the investigators will include 2200 patients in 11 countries, i.e. 200 per country. The primary outcome for the cohort study is a descriptive assessment of the concerns, expectations and preferences around dying and end-of-life care of patients and their relatives, in different settings and cultures..
Rationale: In the EU about 4 million people yearly die from a chronic illness. Many of these people die in pain or distress. Care for dying patients and their close relatives is often suboptimal. Objective: To contribute to high-quality personalized care at the end of life by: 1. Providing in-depth understanding of the concerns, expectations and preferences of patients in the last phase of life and their relatives 2. Understanding the cultural, gender, age, healthcare -related and socio-economic variance in these concerns expectations and preferences Study design: The iLIVE project involves a cohort study in which patients with an estimated life expectancy of six months or less are followed until they die. In total, the investigators will include 2200 patients in 11 countries, i.e. 200 per country. Participants are requested to also involve a close relative. Both patients and relatives are asked to fill in a questionnaire, at baseline and after four weeks. If patients die during the study, the relative is asked to fill in a post-bereavement questionnaire. Medical files are studied to assess health care use in the last days of life. Main study endpoints: The primary outcome for the cohort study is a descriptive assessment of patients' concerns, expectations and preferences around dying and end-of-life care, at baseline and after one month of follow-up. Potential risks and benefits associated with participation: The study population concerns vulnerable people who may experience fluctuating symptoms and levels of suffering across their disease trajectory. The investigators acknowledge the risk of overburdening or stigmatizing participants. If patients feel burdened by participating in the study, they are encouraged to indicate that. The investigators will develop a protocol for researchers and interviewers to address such situations.
Study Type
OBSERVATIONAL
Enrollment
1,500
No intervention involved
Pallium Latinoamérica
Buenos Aires, Argentina
University Hospital Cologne
Cologne, Germany
Landspitali National University Hospital of Iceland
Reykjavik, Iceland
Concerns, expectations and preferences around dying and end-of-life care (descriptive assessment of prevalence)
Self developed questions, adapted from the Serious Illness Conversation Guide and the AEOLI questionnaire.
Time frame: Baseline
Concerns, expectations and preferences around dying and end-of-life care (descriptive assessment of prevalence)
Self developed questions, which were inspired by the Serious Illness Conversation Guide and the AEOLI questionnaire.
Time frame: One month of follow-up
Edmonton Symptom Assessment Scale (range 0-10, with higher score meaning worse outcome)
Symptoms
Time frame: At baseline and after one month of follow-up
European Organisation for Research and Treatment of Cancer Quality of Life C15-Palliative Care questionnaire, quality of life item (range 1-7, with higher score indicating better outcome)
Quality of life
Time frame: At baseline and after one month of follow-up
EuroQol-5d questionnaire (range 1-5 per item, with higher score indicating worse outcome)
Quality of life
Time frame: At baseline and after one month of follow-up
ICECAP Supportive Care Measure (range 1-4 per item, with higher score indicating worse outcome)
Experience of support
Time frame: At baseline and after one month of follow-up
Use of medical interventions (hospitalisation, medication, surgery, other interventions)
Retrospective assessment for patients who die during follow-up of medical interventions in the last week of patients' life, using a self-developed checklist
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Agnes van der Heide
Rotterdam, Netherlands
Arohanui Hospice Service
Palmerston North, New Zealand
Haukeland University Hospital
Bergen, Norway
University Clinic for Respiratory and Allergic Diseases Golnik
Ljubljana, Slovenia
Centro de Cuidados Paliativos Cudeca
Málaga, Spain
Skåne University Hospital
Lund, Sweden
Bern University Hospital
Bern, Switzerland
...and 1 more locations
Time frame: One week
Bereaved relatives' experiences
International Care of the dying questionnaire (descriptive), Hogan Grief Reaction Checklist (despair (13 items) and personal growth (12 items) scales, range 1-5 per item)
Time frame: 8-10 weeks post-bereavement